Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
Background/Objective: To date, no clinical trials have evaluated the therapeutic response among psoriasis patients switching from ustekinumab to secukinumab. The objective of this study was to report our experience of treating psoriasis patients with secukinumab therapy who had ever received ustekin...
Main Authors: | Ting-Shun Wang, Chih-Chieh Chan, Hsien-Yi Chiu, Tsen-Fang Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-03-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1027811716300933 |
Similar Items
-
Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
by: Amy J. Petty, BS, et al.
Published: (2020-08-01) -
Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
by: Jerry Bagel, et al.
Published: (2018-10-01) -
Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis
by: Misbah N. Ghazanfar, et al.
Published: (2019-07-01) -
Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center
by: Seung-Won Jung, et al.
Published: (2022-05-01) -
Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022-12-01)